Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
4/11/2013 9:15:35 AM
More...
|
Relievant Medsystems Inks $30 Million Series D Financing
3/28/2012 7:42:15 AM
More...
|
Relievant Medsystems Begins SMART Trial for the Alleviation of Chronic Low Back Pain
10/31/2011 10:48:32 AM
More...
|
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
8/23/2011 6:48:53 AM
More...
|
Relievant Medsystems Receives FDA Approval to Begin Pivotal Study to Evaluate the Intracept System for Minimally Invasive Treatment of Chronic Low Back Pain
8/8/2011 11:51:26 AM
More...
|
Relievant Medsystems Announces Completion of $20 Million Financing
7/7/2009 7:35:42 AM
More...
|